Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The Opioid System and Brain Development: Effects of Methadone on the Oligodendrocyte Lineage and the Early Stages of Myelination.
Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis?
Importance of Human Leukocyte Antigen (HLA) Class I and II Alleles on the Risk of Multiple Sclerosis.
Pathology of Multiple Sclerosis.
Antidepressant activity of fingolimod in mice.
Evaluating cognitive rehabilitation in multiple sclerosis: on the bumpy road to establishing evidence.
Immunotherapy of Multiple Sclerosis : The State of the Art.
Minoderm
Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies.
Natalizumab Therapy for Multiple Sclerosis.
Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity.
Feedforward postural control in individuals with multiple sclerosis during load release.
Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis.
A randomized clinical trial of valacyclovir in multiple sclerosis.
Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis.
The causal cascade to multiple sclerosis: a model for MS pathogenesis.
CNS diseases and uveitis.
Rationale and design of a clinical trial investigating resistance training as an aid to smoking cessation in persons with multiple sclerosis.
Autologous T Cell Vaccine (TCV) for Multiple Sclerosis (TERMS)
Neuromyelitis optica in a patient with pemphigus foliaceus.
Multiple sclerosis in children and adolescents: incidence and clinical picture - new insights from the nationwide German surveillance (2009-2011).
Rising incidence of multiple sclerosis in females associated with urbanization.
Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use.
Epidemiology of amyotrophic lateral sclerosis in Isfahan, Iran.
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses.

Pages